Drug Res (Stuttg) 2014; 64(10): 505-509
DOI: 10.1055/s-0034-1368720
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Synthesis, Antimicrobial and Anticancer Evaluation of N′-(Substituted Benzylidene)-2-(Benzo[d]oxazol-3(2H)-yl)acetohydrazide Derivatives

P. Rohilla
1   Department of Pharmaceutical Chemistry, Hindu College of Pharmacy, Sonepat, India
,
A. Deep
2   Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India
,
M. Kamra
1   Department of Pharmaceutical Chemistry, Hindu College of Pharmacy, Sonepat, India
,
B. Narasimhan
2   Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India
,
K. Ramasamy
3   Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), 42300 Bandar Puncak Alam, Selangor, Malaysia
4   Collaborative Drug Discovery Research (CDDR) Group, Brain and ­Neuroscience Communities of Research, Universiti Teknologi MARA (UiTM), 40450 Shah Alam, Selangor Darul Ehsan, Malaysia
,
V. Mani
3   Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), 42300 Bandar Puncak Alam, Selangor, Malaysia
5   Collaborative Drug Discovery Research (CDDR) Group, Brain and ­Neuroscience Communities of Research, Universiti Teknologi MARA (UiTM), 40450 Shah Alam, Selangor Darul Ehsan, Malaysia
,
R. K. Mishra
3   Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), 42300 Bandar Puncak Alam, Selangor, Malaysia
5   Collaborative Drug Discovery Research (CDDR) Group, Brain and ­Neuroscience Communities of Research, Universiti Teknologi MARA (UiTM), 40450 Shah Alam, Selangor Darul Ehsan, Malaysia
,
S. M. Lim
3   Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), 42300 Bandar Puncak Alam, Selangor, Malaysia
4   Collaborative Drug Discovery Research (CDDR) Group, Brain and ­Neuroscience Communities of Research, Universiti Teknologi MARA (UiTM), 40450 Shah Alam, Selangor Darul Ehsan, Malaysia
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 28. September 2013

accepted 11. November 2013

Publikationsdatum:
03. Juli 2014 (online)

Preview

Abstract

A series of N′-(substituted benzylidene)-2-(benzo[d]oxazol-3(2H)-yl)acetohydrazide derivatives was synthesized and evaluated for its in vitro antimicrobial and anticancer activities. Antimicrobial activity results revealed that compound 12 was found to be the most potent antimicrobial agent. Results of anticancer study indicated that the synthesized compounds exhibited average anticancer potential. Compound 7 (IC 50 =3.12 µM) and compound 16 (IC 50 =2.88 µM) were found to be most potent against breast cancer (MCF7) cell lines. In conclusion, compound 12 and 16 have the potential to be selected as lead compound for the developing of novel antimicrobial and anticancer agents respectively.